Association between a combined oral contraceptive and the erythema nodosum: a case report
DOI:
https://doi.org/10.32385/rpmgf.v40i2.13844Keywords:
Erythema nodosum, Hormonal contraception, Prednisolone, Case reportAbstract
Introduction: Erythema nodosum is a rare disease whose pathophysiology is based on a type 4 delayed hypersensitivity response and its most common form of presentation is in the form of bilateral and symmetrical nodules and cutaneous plaques, predominantly affecting the pre-tibial region. Although the idiopathic etiology is still quite frequent, close to half of the cases are of secondary etiology, with oral contraceptives being amongst the most associated drugs with this entity, and this causal relationship being described for a greater number of estroprogestative associations. A rare case of erythema nodosum secondary to the association of ethinyl estradiol 0.03mg + levonorgestrel 0.15mg is described.
Case description: We report a case of a 20-year-old woman who developed painful unilateral nodules in the pre-tibial region, related to the initiation of the combination of ethinyl estradiol 0.03mg, and levonorgestrel 0.15mg. The user describes the injuries as being longstanding, although she has never sought medical care in the past. After further investigation of the clinical history and suspicion of the causal relationship between the combined oral contraceptive and the appearance of lesions compatible with erythema nodosum, it was decided to suspend the same and start prednisolone 20mg/day, with the user having a very favorable evolution. After discussing the existing therapeutic options, the user chose to switch to ImplanonÒ.
Conclusion: The literature is increasingly reporting the causal relationship between oral contraceptives, not only the combined type but also the isolated type, and the appearance of erythema nodosum. This is a rare and complex relationship. When a patient starts with painful nodules, a case of erythema nodosum must be considered, being aware of potential triggers - as combined oral contraceptives. In these cases, options must be explained to the user; therapeutic suspension is not the only way.
Downloads
References
Bondi EE, Margolis DJ, Lazarus GS. Panniculitis. In: Freedberg IM, Fitzpatrick TB, Eisen AZ, Wolff K, Austen KF, et al, editors. Fitzpatrick’s dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. chapter 70. ISBN 9780079129383
Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007;75(5):695-700.
Requena L, Yus ES. Panniculitis. Part I: mostly septal panniculitis. J Am Acad Dermatol. 2001;45(2):163-83.
Singer R, Özekinci S. Etiological factors and histopathological features in erythema nodosum: a 6-year retrospective cross-sectional study. Acta Dermatovenerol Alp Pannonica Adriat. 2021;30(2):57-61.
Requena L, Sánchez Yus E. Erythema nodosum. Semin Cutan Med Surg. 2007;26(2):114-25.
Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021;22(3):367-78.
Patterson JW. Panniculitis. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia: Elsevier Saunders; 2012. p. 1641.
García-Porrúa C, González-Gay MA, Vázquez-Caruncho M, López-Lazaro L, Lueiro M, Fernández ML, et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum. 2000;43(3):584-92.
Mert A, Kumbasar H, Ozaras R, Erten S, Tasli L, Tabak F, et al. Erythema nodosum: an evaluation of 100 cases. Clin Exp Rheumatol. 2007;25(4):563-70.
Porges T, Shafat T, Sagy I, Zeller L, Bartal C, Khutarniuk T, et al. Clinical, epidemiological, and etiological changes in erythema nodosum. Isr Med Assoc J. 2018;20(12):770-2.
Bartelsmeyer JA, Petrie RH. Erythema nodosum, estrogens, and pregnancy. Clin Obstet Gynecol. 1990;33(4):777-81.
Taaffe A, Finlay AY, Marks R. Erythema nodosum and oral contraceptives. Br Med J. 1977;2(6098):1353.
Min MS, Fischer R, Fournier JB. Unilateral erythema nodosum following norethindrone acetate, ethinyl estradiol, and ferrous fumarate combination therapy. Case Rep Obstet Gynecol. 2016;2016:5726416.
Tomasini C, Lentini F, Borroni G. The role of skin biopsy in diagnosis of panniculitides. G Ital Dermatol Venereol. 2013;148(4):335-49.
Holcomb FD. Erythema nodosum associated with the use of an oral contraceptive: report of a case. Obstet Gynecol. 1965;25:156-7.
Silva FS, Carreira P, Serra S. Um caso exuberante de eritema nodoso associado a desogestrel [An exuberant case of erythema nodosum associated with desogestrel]. Rev Port Med Geral Fam. 2021;37(3):243-7. Portuguese
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Portuguese Journal of Family Medicine and General Practice
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.
